New Delhi, India -- (SBWIRE) -- 05/11/2017 -- The Report "Natural Killer Cells Therapies - Competitive Landscape, Technology, and Pipeline Analysis, 2017" covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell-based therapies along with drugs that augment (enhance or activate) the NK cells. The Report provides in-depth analysis of the Natural Killer Cell-based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, Technologies and Targeted antigens. The Report provides the NK Cell-based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis.

Reports Highlights:

NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies.

Collaborations & partnering deals
Current Prominent Research Areas and Key Players
Pipeline product profiles NK Cell therapy Technologies and NK cell Augmenting Therapies
Licensing opportunities
Market Drivers and Barriers

Scope

Overview of the global NK cell therapy pipeline scenario, products, and associated companies information

Coverage of global NK cell therapies and drugs that enhance the activity of NK under development

Competitive landscape of products for key players and related indications

Coverage of licensors, collaborators and development partners, deal terms and deal values estimation

Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities

Highlights of licensing & collaboration opportunities and funding details

Highlights of latest NK cell therapy technologies and NK cell augmenting therapies and innovative companies

Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

For more information please click here

About DelveInsight

DelveInsight is a Business Consultant company and serves as a Knowledge partner across the value chain of Pharmaceutical Industry. With the use of proprietary databases and analytical models, DelveInsight provides cutting-edge market and pipeline analysis and API intelligence across all therapy areas to the Pharma and biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios, and companies.